Baculovirus Expression System Market Size is valued at USD 374.79 Mn in 2023 and is predicted to reach USD 660.97 Mn by the year 2031 at a 7.43% CAGR during the forecast period for 2024-2031.
The baculovirus vector system induces recombinant protein expression in insect cell cultures. It is one of the most adaptable and robust methods for the eukaryotic expression of recombinant proteins. This technique allows for the efficient manufacture of proteins with the appropriate post-translational modifications, making it ideal for use in research of protein function. Safety, quick vector synthesis, the flexibility to use serum-free medium, and efficient protein folding and post-translational modifications are just a few of the many benefits of this technology. Furthermore, the market for biosimilars has grown as the patents on several successful biologics have expired. The biosimilar industry is increasingly turning to baculovirus expression to speed up and reduce the cost of making biosimilar versions of antibodies and proteins. As a result, the baculovirus expression system market is anticipated to benefit from expanding the biologics and biosimilar industries.
However, market expansion is anticipated to be hampered by issues that include the high cost of research and development, the scarcity of supporting infrastructure, the high price of treatment, and the prevalence of market consolidation. Low-cost substitutes, stringent regulatory approvals, the high cost of protein therapy, and a lack of suitable infrastructure in low- and middle-income countries are all expected to slow market expansion over the next few years. The effects of COVID-19 on the market have been adverse. The suspension of elective surgical procedures hampered the potential for the need to expand. In addition, the market was hampered during this pandemic era by restrictions enacted in response to the movement. However, with the forthcoming easings, a recovery is anticipated in the market.
The baculovirus expression system market is segmented based on product type, application, and end-use industry. According to product type, the market comprises baculovirus, expression vector, reagents, and others. By application, the market is segmented into therapeutics, Vaccines, Protein Purification, and Others. By end-use industry, the market is segmented into biopharmaceutical companies, research institutes, and others.
The expression vectors segment is likely to hold a significant global market share in 2024 in baculovirus expression system market. Expression vectors have been used to transfer genes into plants and animals, resulting in transgenic species used in agriculture. Rice plants have been modified to produce beta-carotene, a precursor to vitamin A, using expression vectors.
The biopharmaceutical industry leads because many medicine manufacturers have developed efficient manufacturing procedures that help keep their goods affordable. Any group working to expand people's access to low-cost medical care may benefit, especially in countries like the US, Germany, the UK, China, and India.
The North American baculovirus expression system market is expected to record the maximum market share in revenue in the near future. It can be attributed to the high concentration of top pharmaceutical firms, the massive funding of research and development, and the swift uptake of cutting-edge technologies. In addition, Asia Pacific is estimated to grow rapidly in the global baculovirus expression system market because global biopharma enterprises are increasingly outsourcing bioproduction in light of expanding demand for protein therapies, increasing investments in R&D infrastructure, and rising outsourcing rates.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 374.79 Mn |
|
Revenue Forecast In 2031 |
USD 660.97 Mn |
|
Growth Rate CAGR |
CAGR of 7.43 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, Product Type, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek and othes |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Baculovirus Expression System Market Snapshot
Chapter 4. Global Baculovirus Expression System Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Baculovirus
5.2.2. Expression Vector
5.2.3. Reagents
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Therapeutics
6.2.2. Vaccines
6.2.3. Protein Purification
6.2.4. Others
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Biopharmaceutical Companies
7.2.2. Research Institutes
7.2.3. Others
Chapter 8. Baculovirus Expression System Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Product Type, 2024-2031
8.1.2. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.3. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.1.4. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2024-2031
8.2.2. Europe Baculovirus Expression System Market revenue (US$ Million) By Application, 2024-2031
8.2.3. Europe Baculovirus Expression System Market revenue (US$ Million) By End User, 2024-2031
8.2.4. Europe Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2024-2031
8.3.2. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Application, 2024-2031
8.3.3. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By End User, 2024-2031
8.3.4. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
8.4.2. Latin America Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.4.3. Latin America Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
8.4.4. Latin America Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2024-2031
8.5.4. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific,
9.2.2. Merck KGaA,
9.2.3. Takara Bio,
9.2.4. Agilent Technologies,
9.2.5. Oxford Expression Technologies,
9.2.6. Promega Corporation,
9.2.7. Qiagen N.V.,
9.2.8. Bio-Rad Laboratories,
9.2.9. New England Biolabs,
9.2.10. Genscript Biotech Corporation,
9.2.11. Syngene International Limited,
9.2.12. Sartorius AG,
9.2.13. Aragen Bioscience,
9.2.14. Vivopure,
9.2.15. Creative Biogene,
9.2.16. Absolute Antibody,
9.2.17. Rockland Immunochemicals,
9.2.18. Protein Technologies Inc.,
9.2.19. Proteogenix,
9.2.20. Virovek
Baculovirus Expression System Market By Product Type-
Baculovirus Expression System Market By Application-
Baculovirus Expression System Market By End User-
Baculovirus Expression System Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
